GlassScriptPhysician profile
Katherine L White
NPI 1043326937
$28,072.46
in general payments reported to CMS, 2019-2025
19 companies · $2,719 in 2025
The $2,719 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,662 · 2020: $169 · 2021: $8,193 · 2022: $5,660 · 2023: $4,380 · 2024: $5,290 · 2025: $2,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $1,172 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,022.20 |
| Food and Beverage | $1,171.86 |
| Education | $194.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15,834.61 | 2019-2023 | |
| Abbvie INC. | $10,815.56 | 2019-2025 | Botox, Rinvoq |
| Janssen Biotech, INC. | $304.76 | 2019-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $202.63 | 2023-2024 | Sotyktu |
| Leo Pharma INC. | $201.76 | 2019-2022 | |
| Pfizer INC. | $120.79 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $98.94 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2022 | |
| Merz North America, INC. | $79.34 | 2022-2025 | |
| Biofrontera INC. | $61.28 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Genzyme Corporation | $48.66 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $39.23 | 2019 | |
| Ucb, INC. | $38.25 | 2019-2020 | |
| Dermavant Sciences, INC. | $28.92 | 2024 | Vtama |
| Galderma Laboratories, L.P. | $28.69 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aclaris Therapeutics, INC. | $28.52 | 2019 | |
| Celgene Corporation | $24.31 | 2019 | |
| Dermira, INC. | $18.27 | 2019 | |
| Arcutis Biotherapeutics, INC. | $17.95 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.